Contract 75F40123C00204
The Corporation Of Mercer University · Department Of Health And Human Services · July 29, 2024
The Corporation Of Mercer University was awarded a federal contract by Department Of Health And Human Services (Food And Drug Administration) on July 29, 2024 for $256,000 of work in research and development in biotechnology (except nanobiotechnology). Performance is in Macon, GA. It was awarded under full and open competition. The contract has been modified 2 times since the base award It uses firm fixed-price contract pricing. The most recent modification was on December 9, 2025. If all options are exercised, the contract could reach $507,000.
Contract details
- PIID
- 75F40123C00204
- Award type
- Definitive Contract
- Pricing
- Firm Fixed Price
- Set-aside
- No Set Aside Used.
- Competition
- Full And Open Competition
- NAICS
- 541714 · Research And Development In Biotechnology (Except Nanobiotechnology)
- Product / service
- Health R&D Services; Health Care Services; Basic Research
- Place of performance
- Macon, GA
- First action
- July 29, 2024
- Latest action
- December 9, 2025
Description
IN VITRO TESTS TO SUPPORT BIOEQUIVALENCE DETERMINATION WHEN GENERIC DERMATOLOGICAL FORMULATION HAS DIFFERENCES FROM THE BRAND PRODUCT FORMULATION
Modification timeline
-
December 9, 2025Mod P00005 · Other Administrative Action$375.5K
-
August 7, 2025Mod P00004 · Exercise An Option$375.5K
-
July 29, 2024Mod P00002 · Exercise An Option$244.0K
Similar contracts
| Recipient | Agency | Date | Obligated |
|---|---|---|---|
| Vericel Corporation | Department Of Health And Human Services | April 1, 2026 | $34.88M |
| American College Of Medical Toxicology, Inc. | Department Of Health And Human Services | March 31, 2026 | $0 |
| Ceramedix Holding, Llc | Department Of Health And Human Services | March 31, 2026 | $4.22M |
| Glaxosmithkline, Llc | Department Of Health And Human Services | March 31, 2026 | $7.79M |
| Care Access Research Llc | Department Of Health And Human Services | March 31, 2026 | $2.55M |
| Pattern Bioscience, Inc. | Department Of Health And Human Services | March 31, 2026 | $22.50M |
Top contractors in NAICS 541714
Lifetime obligated dollars across all federal contracts in this NAICS code.
| # | Contractor | Contracts | Obligated |
|---|---|---|---|
| 1 | Amgen USA Inc | 1 | $59.99M |
| 2 | Vericel Corporation | 1 | $34.88M |
| 3 | Spectral Md, Inc. | 1 | $31.67M |
| 4 | Ppd Development Lp | 6 | $31.12M |
| 5 | L3 Technologies, Inc. | 1 | $22.00M |
| 6 | Technical Resources International, Inc. | 6 | $21.80M |
| 7 | Abbott Laboratories | 1 | $21.01M |
| 8 | Paratek Pharmaceuticals, Inc | 1 | $17.47M |
| 9 | Ossium Health, Inc. | 1 | $12.39M |
| 10 | Rho Federal Systems Division Inc | 1 | $8.00M |
Track this on BesaGov
Get a free weekly email when this changes — new awards, new sub-awards, new opportunities. No login required.
Continue learning
Keep researching
Frequently asked questions
What is contract 75F40123C00204?
Contract 75F40123C00204 is a federal contract awarded to The Corporation Of Mercer University by Department Of Health And Human Services on July 29, 2024 for $256,000 of work classified under RESEARCH AND DEVELOPMENT IN BIOTECHNOLOGY (EXCEPT NANOBIOTECHNOLOGY). It has been modified 2 times since the base award.
Who won contract 75F40123C00204?
The Corporation Of Mercer University won contract 75F40123C00204 from Department Of Health And Human Services.
How much is contract 75F40123C00204 worth?
Contract 75F40123C00204 has obligated $256,000 to date, with a total potential value of $507,000 if all options are exercised.